HEPATECT CP Solution for infusion Ref.[9855] Active ingredients: Human hepatitis B immunoglobulin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Biotest Pharma GmbH, Landsteinerstrasse 5, 63303 Dreieich, Germany, Tel.: (49) 6103 801-0, fax: (49) 6103 801 150, Email: mail@biotest.com

Product name and form

Hepatect CP 50 IU/ml solution for infusion.

Pharmaceutical Form

Solution for infusion.

The solution is clear or slightly opalescent and colourless to pale yellow.

Qualitative and quantitative composition

Human hepatitis B immunoglobulin.

Human protein 50 g/l of which at least 96% is IgG, with a content of antibodies to Hepatitis B virus surface antigen (HBs) of 50 IU/ml.

Each vial of 2 ml contains: 100 IU.

Each vial of 10 ml contains: 500 IU.

Each vial of 40 ml contains: 2000 IU.

Each vial of 100 ml contains: 5000 IU.

Distribution of IgG subclasses (approx. values):

IgG1: 59%
IgG2: 35%
IgG3: 3%
IgG4: 3%

The maximum IgA content is 2,000 micrograms/ml.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Human hepatitis B immunoglobulin

Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure.

List of Excipients

Glycine
Water for injections

Pack sizes and marketing

Hepatect CP is a ready-for-use solution for infusion provided in vials (Type II glass) with a stopper (bromobutyl) and a cap (aluminium):

Pack size of 1 vial with 2 ml, 10 ml, 40 ml or 100 ml solution.

Marketing authorization holder

Biotest Pharma GmbH, Landsteinerstrasse 5, 63303 Dreieich, Germany, Tel.: (49) 6103 801-0, fax: (49) 6103 801 150, Email: mail@biotest.com

Marketing authorization dates and numbers

PL 04500/0006

12/04/2015

Drugs

Drug Countries
HEPATECT Austria, Brazil, Spain, Finland, Ireland, Israel, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.